Variant report
Variant | nsv946504 |
---|---|
Chromosome Location | chr1:171652643-171653781 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:24)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:24 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr1:171653118-171653351 | K562 | blood: | n/a | n/a |
2 | CUX1 | chr1:171653114-171653222 | K562 | blood: | n/a | n/a |
3 | EP300 | chr1:171653131-171653242 | K562 | blood: | n/a | n/a |
4 | FOSL2 | chr1:171653346-171653581 | HepG2 | liver: | n/a | n/a |
5 | GATA1 | chr1:171652830-171653609 | PBDE | blood: | n/a | n/a |
6 | GATA2 | chr1:171652992-171653306 | K562 | blood: | n/a | n/a |
7 | HEY1 | chr1:171653367-171653607 | K562 | blood: | n/a | n/a |
8 | HEY1 | chr1:171653395-171653554 | HepG2 | liver: | n/a | n/a |
9 | JUND | chr1:171653396-171653567 | HepG2 | liver: | n/a | n/a |
10 | NR2F2 | chr1:171652961-171653335 | K562 | blood: | n/a | n/a |
11 | POLR2A | chr1:171653390-171653546 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | POLR2A | chr1:171653275-171653609 | Hela-S3 | cervix: | n/a | n/a |
13 | POLR2A | chr1:171653328-171653596 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr1:171653495-171653528 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | POLR2A | chr1:171653353-171653559 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | POLR2A | chr1:171653277-171653605 | GM12878 | blood: | n/a | n/a |
17 | SIN3AK20 | chr1:171653392-171653498 | HepG2 | liver: | n/a | n/a |
18 | SPI1 | chr1:171653005-171653214 | K562 | blood: | n/a | n/a |
19 | TAL1 | chr1:171653023-171653345 | K562 | blood: | n/a | n/a |
20 | TEAD4 | chr1:171652999-171653268 | K562 | blood: | n/a | n/a |
21 | TEAD4 | chr1:171652969-171653399 | K562 | blood: | n/a | n/a |
22 | ZBTB33 | chr1:171653302-171653651 | K562 | blood: | n/a | n/a |
23 | ZMIZ1 | chr1:171653164-171653172 | K562 | blood: | n/a | n/a |
24 | ZNF143 | chr1:171653145-171653182 | K562 | blood: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-VAMP4-4 | chr1:171653555-171654384 | NONHSAT007576 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL4P3 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561524444 | chr1:171652645-171652646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs375938918 | chr1:171652646-171652647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9661596 | chr1:171652664-171652665 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs548297353 | chr1:171652672-171652673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115565507 | chr1:171652675-171652676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530818248 | chr1:171652698-171652699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs61023977 | chr1:171652701-171652702 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs181292470 | chr1:171652714-171652715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs59070139 | chr1:171652719-171652720 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs9662853 | chr1:171652731-171652732 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs10913484 | chr1:171652753-171652754 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs11811780 | chr1:171652759-171652760 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs565753992 | chr1:171652774-171652775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12044749 | chr1:171652805-171652806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575371730 | chr1:171652921-171652922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11799420 | chr1:171652978-171652979 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs557733312 | chr1:171652980-171652981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573083847 | chr1:171653006-171653007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370015344 | chr1:171653014-171653015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538620622 | chr1:171653036-171653037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540506017 | chr1:171653071-171653072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147794540 | chr1:171653115-171653116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529056681 | chr1:171653170-171653171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10913488 | chr1:171653207-171653208 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs536961579 | chr1:171653208-171653209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563481079 | chr1:171653219-171653220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557215360 | chr1:171653223-171653224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531868399 | chr1:171653230-171653231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531029445 | chr1:171653238-171653239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573792928 | chr1:171653248-171653249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552314321 | chr1:171653249-171653250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201030275 | chr1:171653264-171653265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564487893 | chr1:171653293-171653294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528443659 | chr1:171653321-171653322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs151197926 | chr1:171653328-171653329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12095503 | chr1:171653329-171653330 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs185599190 | chr1:171653372-171653373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551187622 | chr1:171653378-171653379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10913489 | chr1:171653384-171653385 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs140160605 | chr1:171653400-171653401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10913490 | chr1:171653401-171653402 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs541502108 | chr1:171653458-171653459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548072842 | chr1:171653462-171653463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567822751 | chr1:171653464-171653465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572816896 | chr1:171653481-171653482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533507651 | chr1:171653552-171653553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555251305 | chr1:171653553-171653554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs573589061 | chr1:171653565-171653566 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs544047168 | chr1:171653566-171653567 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs10913492 | chr1:171653599-171653600 | Enhancers | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 20409316 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:171647800-171652800 | Weak transcription | K562 | blood |
2 | chr1:171652800-171653600 | Enhancers | K562 | blood |
3 | chr1:171653000-171653400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr1:171653000-171654200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |